NLRP3 and chronic kidney disease: Inflammatory responses significantly promote the progression of CKD by activating the NLRP3–ASC–caspase-1 axis to induce and release inflammatory cytokines like IL-1β and IL-18, which play pivotal roles in the onset and advancement of CKD (16).